Pages that link to "Q34443655"

The following pages link to Management of visceral leishmaniasis in rural primary health care services in Bihar, India (Q34443655):

Displaying 22 items.

• Treatment of visceral leishmaniasis: model-based analyses on the spread of antimony-resistant L. donovani in Bihar, India (Q28484459) (← links)
• Arsenic exposure and outcomes of antimonial treatment in visceral leishmaniasis patients in Bihar, India: a retrospective cohort study (Q28543757) (← links)
• Elimination of visceral leishmaniasis on the Indian subcontinent (Q30244956) (← links)
• Options for active case detection of visceral leishmaniasis in endemic districts of India, Nepal and Bangladesh, comparing yield, feasibility and costs (Q33828879) (← links)
• Visceral leishmaniasis in Muzaffarpur district, Bihar, India from 1990 to 2008. (Q33843296) (← links)
• Visceral leishmaniasis and arsenic: an ancient poison contributing to antimonial treatment failure in the Indian subcontinent? (Q34043521) (← links)
• Health & Demographic Surveillance System profile: the Muzaffarpur-TMRC Health and Demographic Surveillance System (Q34309812) (← links)
• Monitoring drug effectiveness in kala-azar in Bihar, India: cost and feasibility of periodic random surveys vs. a health service-based reporting system (Q35154324) (← links)
• Visceral leishmaniasis clinical management in endemic districts of India, Nepal, and bangladesh (Q35977662) (← links)
• Village health workers in Bihar, India: an untapped resource in the struggle against kala-azar (Q36557152) (← links)
• Chronic exposure to arsenic in drinking water can lead to resistance to antimonial drugs in a mouse model of visceral leishmaniasis (Q37377483) (← links)
• Socio-economic aspects of neglected diseases: sleeping sickness and visceral leishmaniasis (Q37811110) (← links)
• Health-seeking behaviour, diagnostics and transmission dynamics in the control of visceral leishmaniasis in the Indian subcontinent (Q39240018) (← links)
• Retrospective Quarterly Cohort Monitoring for patients with Visceral Leishmaniasis in the Indian subcontinent: outcomes of a pilot project (Q39329286) (← links)
• Drug resistance and treatment failure in leishmaniasis: A 21st century challenge. (Q46380663) (← links)
• Low castes have poor access to visceral leishmaniasis treatment in Bihar, India (Q50142265) (← links)
• Socioeconomic benefit to individuals of achieving 2020 targets for four neglected tropical diseases controlled/eliminated by innovative and intensified disease management: Human African trypanosomiasis, leprosy, visceral leishmaniasis, Chagas diseas (Q51740777) (← links)
• Visceral leishmaniasis treatment in the Indian subcontinent: how to reach the most vulnerable. (Q52744493) (← links)
• A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis (Q57392733) (← links)
• Visceral leishmaniasis cyclical trends in Bihar, India - implications for the elimination programme (Q57725662) (← links)
• Visceral leishmaniasis: Spatiotemporal heterogeneity and drivers underlying the hotspots in Muzaffarpur, Bihar, India (Q60046219) (← links)
• Eliminating visceral leishmaniasis in South Asia: the road ahead (Q61811531) (← links)